Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 26:9:992565.
doi: 10.3389/fmed.2022.992565. eCollection 2022.

Recent insights in the role of biomarkers in severe asthma management

Evangelia Fouka  1   2 , Kalliopi Domvri  1   2 , Foteini Gkakou  1   2 , Maria Alevizaki  1   2 , Paschalis Steiropoulos  3 , Despoina Papakosta  1   2 , Konstantinos Porpodis  1   2
Affiliations
Review

Recent insights in the role of biomarkers in severe asthma management

Evangelia Fouka et al. Front Med (Lausanne). .

Abstract

Contemporary asthma management requires a proactive and individualized approach, combining precision diagnosis and personalized treatment. The introduction of biologic therapies for severe asthma to everyday clinical practice, increases the need for specific patient selection, prediction of outcomes and monitoring of these costly and long-lasting therapies. Several biomarkers have been used in asthma in disease identification, prediction of asthma severity and prognosis, and response to treatment. Novel advances in the area of personalized medicine regarding disease phenotyping and endotyping, encompass the development and application of reliable biomarkers, accurately quantified using robust and reproducible methods. The availability of powerful omics technologies, together with integrated and network-based genome data analysis, and microbiota changes quantified in serum, body fluids and exhaled air, will lead to a better classification of distinct phenotypes or endotypes. Herein, in this review we discuss on currently used and novel biomarkers for the diagnosis and treatment of asthma.

Keywords: T2 asthma; biomarkers; microbiome & dysbiosis; non-T2 airway inflammation; omics; severe asthma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Asthma biomarkers categorized as those related to type 2 (T2) Inflammation and those that relate to other biological processes.
See this image and copyright information in PMC

Similar articles

  • Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
    Breiteneder H, Peng YQ, Agache I, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, O'Hehir RE, O'Mahony L, Pfaar O, Torres MJ, Wang DY, Zhang L, Akdis CA. Breiteneder H, et al. Allergy. 2020 Dec;75(12):3039-3068. doi: 10.1111/all.14582. Epub 2020 Sep 30. Allergy. 2020. PMID: 32893900 Free PMC article. Review.
  • Advances and highlights in biomarkers of allergic diseases.
    Ogulur I, Pat Y, Ardicli O, Barletta E, Cevhertas L, Fernandez-Santamaria R, Huang M, Bel Imam M, Koch J, Ma S, Maurer DJ, Mitamura Y, Peng Y, Radzikowska U, Rinaldi AO, Rodriguez-Coira J, Satitsuksanoa P, Schneider SR, Wallimann A, Zhakparov D, Ziadlou R, Brüggen MC, van de Veen W, Sokolowska M, Baerenfaller K, Zhang L, Akdis M, Akdis CA. Ogulur I, et al. Allergy. 2021 Dec;76(12):3659-3686. doi: 10.1111/all.15089. Epub 2021 Sep 27. Allergy. 2021. PMID: 34519063 Free PMC article. Review.
  • Role of T2 inflammation biomarkers in severe asthma.
    Parulekar AD, Diamant Z, Hanania NA. Parulekar AD, et al. Curr Opin Pulm Med. 2016 Jan;22(1):59-68. doi: 10.1097/MCP.0000000000000231. Curr Opin Pulm Med. 2016. PMID: 26574724 Review.
  • Applying personalized medicine to adult severe asthma.
    Tiotiu A. Tiotiu A. Allergy Asthma Proc. 2021 Jan 1;42(1):e8-e16. doi: 10.2500/aap.2021.42.200100. Allergy Asthma Proc. 2021. PMID: 33404396 Review.
  • Asthma Endotyping and Biomarkers in Childhood Asthma.
    Licari A, Castagnoli R, Brambilla I, Marseglia A, Tosca MA, Marseglia GL, Ciprandi G. Licari A, et al. Pediatr Allergy Immunol Pulmonol. 2018 Jun 1;31(2):44-55. doi: 10.1089/ped.2018.0886. Pediatr Allergy Immunol Pulmonol. 2018. PMID: 30069422 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cevhertas L, Ogulur I, Maurer DJ, Burla D, Ding M, Jansen K, et al. . Advances and recent developments in asthma in 2020. Allergy. (2020) 75:3124–46. 10.1111/all.14607 - DOI - PubMed
    1. Seys SF, Quirce S, Agache I, Akdis CA, Alvaro-Lozano M, Antolín-Amérigo D, et al. . Severe asthma: entering an era of new concepts and emerging therapies: highlights of the 4th international severe asthma forum, Madrid, 2018. Allergy. (2019) 74:2244–8. 10.1111/all.13843 - DOI - PubMed
    1. Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: moving toward precision medicine. J Allergy Clin Immunol. (2019) 144:1–12.25. 10.1016/j.jaci.2019.05.031 - DOI - PubMed
    1. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. (2012) 18:716–25. 10.1038/nm.2678 - DOI - PubMed
    1. Fitzpatrick AM, Moore WC. Severe asthma phenotypes - how should they guide evaluation and treatment? J Allergy Clin Immunol Pract. (2017) 5:901–8. 10.1016/j.jaip.2017.05.015 - DOI - PMC - PubMed

LinkOut - more resources